piracetam has been researched along with Myoclonic Jerk in 57 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Levetiracetam was well tolerated (mean dose: 1985 mg/day)." | 6.73 | A pilot trial of levetiracetam in eyelid myoclonia with absences (Jeavons syndrome). ( Biondi, R; Capovilla, G; Coppola, A; Di Bonaventura, C; Fontanillas, L; Giallonardo, AT; Romeo, A; Rubboli, G; Sofia, V; Striano, P; Striano, S; Viri, M; Vitale, G; Zara, F, 2008) |
| " However, because the effects seemed dose-related, the dosage of piracetam needed to be increased until the optimum effects were obtained." | 5.35 | [Effects of piracetam therapy in a case of Lance-Adams syndrome]. ( Hachiya, Y; Hanafusa, Y; Hoshino, A; Kumada, S; Kurihara, E; Okiyama, R; Tomita, S; Yokochi, F, 2009) |
| "Levetiracetam was well tolerated (mean dose: 1985 mg/day)." | 2.73 | A pilot trial of levetiracetam in eyelid myoclonia with absences (Jeavons syndrome). ( Biondi, R; Capovilla, G; Coppola, A; Di Bonaventura, C; Fontanillas, L; Giallonardo, AT; Romeo, A; Rubboli, G; Sofia, V; Striano, P; Striano, S; Viri, M; Vitale, G; Zara, F, 2008) |
| "Disabling myoclonus is the main symptom in long-standing Unverricht-Lundborg disease (ULD), and levetiracetam (LEV) appears to be an effective anticonvulsant with promising short-term antimyoclonic properties." | 2.71 | Antimyoclonic effect of levetiracetam in 13 patients with Unverricht-Lundborg disease: clinical observations. ( Gelisse, P; Genton, P; Magaudda, A, 2004) |
| "Levetiracetam is a relatively new antiepileptic drug, which has been reported to have promising antimyoclonic properties, especially in posthypoxic myoclonus, progressive myoclonic epilepsy (PME) and spinal myoclonus." | 2.71 | Limited efficacy of levetiracetam on myoclonus of different etiologies. ( Ahmed, A; Lim, LL, 2005) |
| "Levetiracetam is a new antiepileptic agent that exerts antimyoclonic effects." | 2.71 | Levetiracetam in patients with cortical myoclonus: a clinical and electrophysiological study. ( Boccella, P; Manganelli, F; Perretti, A; Striano, P; Striano, S, 2005) |
| "Myoclonic jerks are frequently the debut symptom, while tonic-clonic seizures appear later on." | 2.48 | [Juvenile myoclonic epilepsy]. ( Markhus, R; Nakken, KO; Selmer, KK; Syvertsen, MR, 2012) |
| "Epileptic myoclonus is that which forms part of an epileptic syndrome with a genetic or idiopathic cause, or that is due to static encephalopathy." | 2.45 | [Myoclonic spasms: their clinical and neurophysiological characteristics, aetiology and treatment]. ( Erro, ME; Navarro, MC, 2009) |
| "Myoclonus is defined as shock-like, brief involuntary abnormal movements in muscle jerking caused by external stimuli; and it arises from progressive myoclonus epilepsy, post-anoxic encephalopathy and Alzheimer's disease, causing disabling symptoms." | 2.41 | [A pharmacological profile of piracetam (Myocalm), a drug for myoclonus]. ( Nanri, M; Tajima, K, 2000) |
| " Two double-blind comparisons with placebo provided results which allow recommendations for the dosage and usage of piracetam in cortical myoclonus." | 2.40 | Piracetam in the treatment of cortical myoclonus. ( Genton, P; Guerrini, R; Remy, C, 1999) |
| "Myoclonus is a rare, but disabling symptom, occurring in a number of diseases of different origin." | 2.39 | Piracetam in the treatment of myoclonus: an overview. ( Van Vleymen, B; Van Zandijcke, M, 1996) |
| "Early after CA, myoclonus together with a reactive, epileptiform EEG, preserved evoked potentials and brainstem reflexes suggests LAS." | 1.46 | Early Lance-Adams syndrome after cardiac arrest: Prevalence, time to return to awareness, and outcome in a large cohort. ( Aicua Rapun, I; Novy, J; Oddo, M; Rossetti, AO; Solari, D, 2017) |
| "Levetiracetam was the most commonly used initial medication, with the majority (73%) of patients treated achieving partial or complete seizure control." | 1.46 | The clinical and neurobehavioral course of Down syndrome and dementia with or without new-onset epilepsy. ( Chemali, Z; Gholipour, T; Mitchell, S; Sarkis, RA, 2017) |
| "Postanoxic myoclonus is a rare manifestation after an anoxic event, with fewer than 150 cases reported in the literature." | 1.40 | Postanoxic myoclonus: two case presentations and review of medical management. ( Budhram, A; Harvey, D; Lipson, D; Nesathurai, S; Rathbone, MP, 2014) |
| "Improvement of the action myoclonus was observed only after adding levetiracetam." | 1.40 | Improvement of post-hypoxic action myoclonus with levetiracetam add-on therapy: A case report. ( Božić, K; Divjak, I; Gebauer-Bukurov, K; Ješić, A; Sakalaš, L, 2014) |
| "Levetiracetam can suppress sialidosis-related myoclonus but its effects on cerebral metabolism warrant elucidation." | 1.39 | Functional neuroimages of cortical myoclonus altered by levetiracetam in a patient with sialidosis. ( Chen, KF; Lai, SC; Lu, CS; Lu, MK; Tsai, CH; Wu, YC, 2013) |
| "Subacute sclerosing panencephalitis is a devastating progressive degenerative disease of the nervous system presumably caused by a persistent measles virus." | 1.35 | Successful treatment of encephalopathy and myoclonus with levetiracetam in a case of subacute sclerosing panencephalitis. ( Abou-Khalil, BW; Becker, D; Patel, A; Pina-Garza, JE, 2009) |
| "We investigated the effect of LEV on myoclonus in two CBD patients." | 1.35 | Levetiracetam reduces myoclonus in corticobasal degeneration: report of two cases. ( Barsi, P; Farsang, M; Györke, T; Kamondi, A; Kovács, T; Szirmai, I; Vitaszil, E, 2009) |
| " However, because the effects seemed dose-related, the dosage of piracetam needed to be increased until the optimum effects were obtained." | 1.35 | [Effects of piracetam therapy in a case of Lance-Adams syndrome]. ( Hachiya, Y; Hanafusa, Y; Hoshino, A; Kumada, S; Kurihara, E; Okiyama, R; Tomita, S; Yokochi, F, 2009) |
| "in MERRF (myoclonic epilepsy with ragged red fibers) syndrome, because of its interaction with mitochondrial respiration and metabolism." | 1.33 | Antimyoclonic effect of levetiracetam in MERRF syndrome. ( Filosto, M; Galli, R; Mancuso, M; Murri, L; Pizzanelli, C; Siciliano, G, 2006) |
| "Post-anoxic myoclonus is a rare movement disorder manifested by diffuse action-triggered jerking movements that may result in significant disability." | 1.33 | Post-anoxic myoclonus: a case presentation and review of management in the rehabilitation setting. ( Polesin, A; Stern, M, 2006) |
| "He presented with severe myoclonus, which was resistant to conventional therapy and dramatically improved after administration of 12-18 gm/die piracetam." | 1.33 | Suppression of myoclonus in SCA2 by piracetam. ( Barbieri, F; de Falco, A; De Michele, G; De Rosa, A; Filla, A; Rinaldi, C; Striano, P; Striano, S; Tucci, T, 2006) |
| "A patient presented myoclonus involving all parts of the body after laryngospasm." | 1.32 | [Favorable course of Lance-Adams postanoxic action myoclonus]. ( Benabdejlil, M; Benomar, A; Chkili, T; Errguig, L; Messouak, W; Regragui, W; Yahyaoui, M, 2003) |
| "Myoclonus was induced by intraperitoneal injection of 4." | 1.31 | [Effect of piracetam on urea-induced myoclonus in rats]. ( Matsuura, N; Nanri, M; Yamamoto, A, 2000) |
| "Posthypoxic and postencephalitic myoclonus is often poorly controlled with current treatments." | 1.31 | Suppression of post-hypoxic and post-encephalitic myoclonus with levetiracetam. ( Bergin, A; Cho, YW; Kramer, RE; Krauss, GL; Reich, SG, 2001) |
| "Lance-Adams syndrome is usually recognized only in a late phase, preventing the early rehabilitation." | 1.31 | [Treatment and long-term follow-up of post-anoxic myoclonus]. ( Halász, P; Holló, A; Janszky, J, 2001) |
| "Severity of myoclonus did not correlate with that of the other symptoms or with age." | 1.30 | Cortical reflex myoclonus in Rett syndrome. ( Bonanni, P; Guerrini, R; Parmeggiani, A; Parmeggiani, L; Santucci, M; Sartucci, F, 1998) |
| "Propriospinal myoclonus is a subtype of spinal myoclonus characterized by axial flexion or extension jerks, arrhythmic and prolonged muscle bursts with a pattern of activation consistent with a slow conduction within the propriospinal pathways." | 1.30 | [Propriospinal myoclonus induced by relaxation and drowsiness]. ( Arné, P; Dousset, V; Henry, P; Paty, J; Tison, F, 1998) |
| "Treatment with piracetam in 5 patients significantly improved myoclonus." | 1.29 | Cortical myoclonus in Angelman syndrome. ( Bonanni, P; Bureau, M; De Lorey, TM; Dravet, C; Genton, P; Guerrini, R; Livet, MO; Malzac, P; Moncla, A; Sartucci, F; Serratosa, JM; Simi, P; Suisse, G; Thomas, P, 1996) |
| "Piracetam was effective in myoclonus, especially that of cortical origin, in both monotherapy and polytherapy." | 1.29 | Clinical trial of piracetam in patients with myoclonus: nationwide multiinstitution study in Japan. The Myoclonus/Piracetam Study Group. ( Ikeda, A; Kimura, J; Mizuno, Y; Shibasaki, H; Tashiro, K, 1996) |
| "Authors report a case of focal action myoclonus due to a localized hemispheric lesion." | 1.29 | [Myoclonus of focal action and localized hemispheric lesion. A polygraphic and pharmacological study]. ( Bartolomei, F; Bureau, M; Genton, P; Paglia, G; Roger, J, 1995) |
| "We studied 6 patients with myoclonus elicited by flash stimulation (1-15 Hz)." | 1.29 | The pathophysiology and pharmacology of photic cortical reflex myoclonus. ( Artieda, J; Obeso, JA, 1993) |
| "Ten patients with severe disabling myoclonus were treated with clonazepam, sodium valproate, primidone and piracetam alone, or in different combinations." | 1.28 | The treatment of severe action myoclonus. ( Artieda, J; Day, B; Marsden, CD; Obeso, JA; Rothwell, JC; Thompson, P, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (8.77) | 18.7374 |
| 1990's | 12 (21.05) | 18.2507 |
| 2000's | 23 (40.35) | 29.6817 |
| 2010's | 17 (29.82) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aicua Rapun, I | 1 |
| Novy, J | 1 |
| Solari, D | 1 |
| Oddo, M | 1 |
| Rossetti, AO | 1 |
| Orsucci, D | 1 |
| Ienco, EC | 1 |
| Rocchi, A | 1 |
| Siciliano, G | 2 |
| Mancuso, M | 2 |
| Bonuccelli, U | 1 |
| Budhram, A | 1 |
| Lipson, D | 1 |
| Nesathurai, S | 1 |
| Harvey, D | 1 |
| Rathbone, MP | 1 |
| Parissis, D | 1 |
| Ioannidis, P | 1 |
| Karacostas, D | 1 |
| Maison, O | 1 |
| De la Gastine, B | 1 |
| Peter-Derex, L | 1 |
| Berger, C | 1 |
| Goutelle, S | 1 |
| Božić, K | 1 |
| Gebauer-Bukurov, K | 1 |
| Sakalaš, L | 1 |
| Divjak, I | 1 |
| Ješić, A | 1 |
| Park, KM | 1 |
| Han, YH | 1 |
| Kim, TH | 1 |
| Mun, CW | 1 |
| Shin, KJ | 1 |
| Ha, SY | 1 |
| Park, J | 1 |
| Kim, SE | 1 |
| Gholipour, T | 1 |
| Mitchell, S | 1 |
| Sarkis, RA | 1 |
| Chemali, Z | 1 |
| Becker, D | 1 |
| Patel, A | 1 |
| Abou-Khalil, BW | 1 |
| Pina-Garza, JE | 1 |
| Erro, ME | 1 |
| Navarro, MC | 1 |
| Datta, S | 1 |
| Hart, GK | 1 |
| Opdam, H | 1 |
| Gutteridge, G | 1 |
| Archer, J | 1 |
| Kovács, T | 1 |
| Farsang, M | 1 |
| Vitaszil, E | 1 |
| Barsi, P | 1 |
| Györke, T | 1 |
| Szirmai, I | 1 |
| Kamondi, A | 1 |
| Hoshino, A | 1 |
| Kumada, S | 1 |
| Yokochi, F | 1 |
| Hachiya, Y | 1 |
| Hanafusa, Y | 1 |
| Tomita, S | 1 |
| Okiyama, R | 1 |
| Kurihara, E | 1 |
| Venot, M | 1 |
| Weiss, N | 1 |
| Espinoza, S | 1 |
| Imbert, A | 1 |
| Tadie, JM | 1 |
| Fagon, JY | 1 |
| Guerot, E | 1 |
| Diehl, JL | 1 |
| Gentile, V | 1 |
| Brunetto, D | 1 |
| Leo, I | 1 |
| Bonetti, S | 1 |
| Verrotti, A | 1 |
| Franzoni, E | 1 |
| Santana-Cabrera, L | 1 |
| Cáceres-Agra, JJ | 1 |
| Plummer, C | 1 |
| Vogrin, S | 1 |
| Cook, M | 1 |
| Moses, D | 1 |
| Kobayashi, K | 1 |
| Takeuchi, A | 1 |
| Oka, M | 1 |
| Akiyama, M | 1 |
| Ohtsuka, Y | 1 |
| Syvertsen, MR | 1 |
| Markhus, R | 1 |
| Selmer, KK | 1 |
| Nakken, KO | 1 |
| Abourazzak, S | 1 |
| Chaouki, S | 1 |
| Boubou, M | 1 |
| Amrani, M | 1 |
| Atmani, S | 1 |
| Hida, M | 1 |
| Deik, AF | 1 |
| Shanker, VL | 1 |
| Chen, KF | 1 |
| Lai, SC | 1 |
| Wu, YC | 1 |
| Lu, CS | 1 |
| Lu, MK | 1 |
| Tsai, CH | 1 |
| Keswani, SC | 1 |
| Kossoff, EH | 1 |
| Krauss, GL | 2 |
| Hagerty, C | 1 |
| Errguig, L | 1 |
| Benomar, A | 1 |
| Messouak, W | 1 |
| Regragui, W | 1 |
| Benabdejlil, M | 1 |
| Yahyaoui, M | 1 |
| Chkili, T | 1 |
| Imperiale, D | 1 |
| Bortolotto, S | 1 |
| Cucatto, A | 1 |
| Schiffer, P | 1 |
| Cassano, D | 1 |
| Buffa, C | 1 |
| Magaudda, A | 1 |
| Gelisse, P | 1 |
| Genton, P | 5 |
| Lim, LL | 1 |
| Ahmed, A | 1 |
| Winblad, B | 1 |
| Striano, P | 3 |
| Manganelli, F | 1 |
| Boccella, P | 1 |
| Perretti, A | 1 |
| Striano, S | 3 |
| De Rosa, A | 1 |
| Barbieri, F | 1 |
| de Falco, A | 1 |
| Rinaldi, C | 1 |
| Tucci, T | 1 |
| Filla, A | 1 |
| De Michele, G | 1 |
| Galli, R | 1 |
| Pizzanelli, C | 1 |
| Filosto, M | 1 |
| Murri, L | 1 |
| Polesin, A | 1 |
| Stern, M | 1 |
| Lay-Son Rivas, L | 1 |
| Pizarro Segura, J | 1 |
| Meza Flores, R | 1 |
| Sofia, V | 1 |
| Capovilla, G | 1 |
| Rubboli, G | 1 |
| Di Bonaventura, C | 1 |
| Coppola, A | 1 |
| Vitale, G | 1 |
| Fontanillas, L | 1 |
| Giallonardo, AT | 1 |
| Biondi, R | 1 |
| Romeo, A | 1 |
| Viri, M | 1 |
| Zara, F | 1 |
| Bartolomei, F | 1 |
| Bureau, M | 2 |
| Paglia, G | 1 |
| Roger, J | 1 |
| Bhatia, KP | 1 |
| Brown, P | 1 |
| Gregory, R | 1 |
| Lennox, GG | 1 |
| Manji, H | 1 |
| Thompson, PD | 1 |
| Ellison, DW | 1 |
| Marsden, CD | 3 |
| Yamamoto, M | 1 |
| Yamauchi, T | 1 |
| Yamamoto, K | 1 |
| Kobayashi, T | 1 |
| Artieda, J | 3 |
| Obeso, JA | 3 |
| Löscher, W | 1 |
| Hönack, D | 1 |
| Guerrini, R | 4 |
| De Lorey, TM | 1 |
| Bonanni, P | 2 |
| Moncla, A | 1 |
| Dravet, C | 1 |
| Suisse, G | 1 |
| Livet, MO | 1 |
| Malzac, P | 1 |
| Thomas, P | 1 |
| Sartucci, F | 2 |
| Simi, P | 1 |
| Serratosa, JM | 1 |
| Ikeda, A | 1 |
| Shibasaki, H | 1 |
| Tashiro, K | 1 |
| Mizuno, Y | 1 |
| Kimura, J | 1 |
| Van Vleymen, B | 1 |
| Van Zandijcke, M | 1 |
| Parmeggiani, L | 1 |
| Santucci, M | 1 |
| Parmeggiani, A | 1 |
| Tison, F | 1 |
| Arné, P | 1 |
| Dousset, V | 1 |
| Paty, J | 1 |
| Henry, P | 1 |
| Remy, C | 1 |
| Nanri, M | 2 |
| Yamamoto, A | 1 |
| Matsuura, N | 1 |
| Tajima, K | 1 |
| Bergin, A | 1 |
| Kramer, RE | 1 |
| Cho, YW | 1 |
| Reich, SG | 1 |
| Janszky, J | 1 |
| Holló, A | 1 |
| Halász, P | 1 |
| Harsha, AB | 1 |
| Pai, N | 1 |
| Shenoy, D | 1 |
| Chakrapani, IM | 1 |
| Bhat, IG | 1 |
| Frucht, SJ | 1 |
| Cremieux, C | 1 |
| Serratrice, G | 1 |
| Fahn, S | 1 |
| Rothwell, JC | 2 |
| Day, B | 1 |
| Thompson, P | 1 |
| Quinn, N | 1 |
| Luquin, MR | 1 |
| Vaamonde, J | 1 |
| Kim, JS | 2 |
| Lee, SA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Open Label Controlled Trial of Gluten-Free Diet in Patients With Gluten-Sensitivity and Cerebellar Ataxia[NCT00006492] | 150 participants | Observational | 2000-11-30 | Completed | |||
| Effects of Levetiracetam on Cortical Excitability in Humans[NCT00006191] | 14 participants | Observational | 2000-08-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 reviews available for piracetam and Myoclonic Jerk
| Article | Year |
|---|---|
[Myoclonic spasms: their clinical and neurophysiological characteristics, aetiology and treatment].
Topics: 5-Hydroxytryptophan; Anticonvulsants; Antidepressive Agents, Second-Generation; Diagnosis, Different | 2009 |
[Juvenile myoclonic epilepsy].
Topics: Adolescent; Anticonvulsants; Diagnosis, Differential; Electroencephalography; Female; Humans; Lamotr | 2012 |
Piracetam: a review of pharmacological properties and clinical uses.
Topics: Anemia, Sickle Cell; Animals; Cerebrovascular Circulation; Cognition Disorders; Drug Evaluation; Dys | 2005 |
Progressive myoclonic ataxia associated with coeliac disease. The myoclonus is of cortical origin, but the pathology is in the cerebellum.
Topics: Adult; Aged; Ataxia; Celiac Disease; Cerebellum; Cerebral Cortex; Clonazepam; Electrophysiology; Fem | 1995 |
Piracetam in the treatment of myoclonus: an overview.
Topics: Activities of Daily Living; Brain; Clinical Trials as Topic; Double-Blind Method; Humans; Myoclonus; | 1996 |
Piracetam in the treatment of cortical myoclonus.
Topics: Clinical Trials as Topic; Disease Progression; Drug Administration Schedule; Humans; Myoclonus; Neur | 1999 |
[A pharmacological profile of piracetam (Myocalm), a drug for myoclonus].
Topics: Animals; Anticonvulsants; Clinical Trials, Phase II as Topic; Clonazepam; Disease Models, Animal; Dr | 2000 |
4 trials available for piracetam and Myoclonic Jerk
| Article | Year |
|---|---|
Antimyoclonic effect of levetiracetam in 13 patients with Unverricht-Lundborg disease: clinical observations.
Topics: Adolescent; Adult; Age of Onset; Anticonvulsants; Drug Therapy, Combination; Female; Humans; Levetir | 2004 |
Limited efficacy of levetiracetam on myoclonus of different etiologies.
Topics: Adult; Anticonvulsants; Female; Humans; Levetiracetam; Male; Middle Aged; Myoclonus; Piracetam | 2005 |
Levetiracetam in patients with cortical myoclonus: a clinical and electrophysiological study.
Topics: Adult; Aged; Anticonvulsants; Cerebral Cortex; Electroencephalography; Evoked Potentials, Somatosens | 2005 |
A pilot trial of levetiracetam in eyelid myoclonia with absences (Jeavons syndrome).
Topics: Adolescent; Adult; Anticonvulsants; Child; Comorbidity; Drug Therapy, Combination; Epilepsies, Myocl | 2008 |
46 other studies available for piracetam and Myoclonic Jerk
| Article | Year |
|---|---|
Early Lance-Adams syndrome after cardiac arrest: Prevalence, time to return to awareness, and outcome in a large cohort.
Topics: Adult; Aged, 80 and over; Anticonvulsants; Cardiopulmonary Resuscitation; Clonazepam; Drug Combinati | 2017 |
Levetiracetam-responsive myoclonus in spinocerebellar ataxia type 15.
Topics: Anticonvulsants; Female; Humans; Inositol 1,4,5-Trisphosphate Receptors; Levetiracetam; Mutation; My | 2013 |
Postanoxic myoclonus: two case presentations and review of medical management.
Topics: Aged; Anticonvulsants; Clonazepam; Drug Therapy, Combination; Humans; Hypoxia; Levetiracetam; Male; | 2014 |
Levetiracetam as alternative treatment in Jeavons syndrome.
Topics: Adult; Anticonvulsants; Epilepsy, Absence; Female; Humans; Levetiracetam; Myoclonus; Piracetam | 2014 |
[Subcutaneous administration of levetiracetam in geriatrics].
Topics: Aged, 80 and over; Anticonvulsants; Arousal; Electroencephalography; Geriatrics; Humans; Injections, | 2015 |
Improvement of post-hypoxic action myoclonus with levetiracetam add-on therapy: A case report.
Topics: Accidents, Traffic; Anticonvulsants; Electroencephalography; Fracture Fixation, Internal; Humans; Hy | 2014 |
Increased functional connectivity between motor and sensory cortex in a patient with Lance-Adams syndrome.
Topics: Cardiopulmonary Resuscitation; Cerebral Cortex; Electrocardiography; Electroencephalography; Epiglot | 2015 |
The clinical and neurobehavioral course of Down syndrome and dementia with or without new-onset epilepsy.
Topics: Adult; Anticonvulsants; Dementia; Disease Progression; Down Syndrome; Epilepsy; Female; Humans; Leve | 2017 |
Successful treatment of encephalopathy and myoclonus with levetiracetam in a case of subacute sclerosing panencephalitis.
Topics: Anticonvulsants; Blood Chemical Analysis; Brain; Cerebrospinal Fluid; Child; Electroencephalography; | 2009 |
Post-hypoxic myoclonic status: the prognosis is not always hopeless.
Topics: Aged; Anticonvulsants; Critical Care; Female; Heart Arrest; Humans; Hypoxia; Levetiracetam; Myoclonu | 2009 |
Levetiracetam reduces myoclonus in corticobasal degeneration: report of two cases.
Topics: Anticonvulsants; Female; Humans; Levetiracetam; Male; Middle Aged; Myoclonus; Neurodegenerative Dise | 2009 |
[Effects of piracetam therapy in a case of Lance-Adams syndrome].
Topics: Adolescent; Anticonvulsants; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Ga | 2009 |
Improvement of early diagnosed post-anoxic myoclonus with levetiracetam.
Topics: Adolescent; Anticonvulsants; Early Diagnosis; Female; Humans; Hypoxia, Brain; Levetiracetam; Male; M | 2011 |
Clinical and neuropsychological considerations in a case of unrecognized myoclonic epileptic jerks dramatically controlled by levetiracetam.
Topics: Anticonvulsants; Child; Cognition Disorders; Electroencephalography; Epilepsies, Myoclonic; Female; | 2010 |
[Reply to the article "Effectiveness of levetiracetam in the treatment of two cases of status myoclonicus due to hypoxic encephalopathy"].
Topics: Anticonvulsants; Female; Humans; Male; Myoclonus; Piracetam | 2011 |
Curing of oscillating larynx by levetiracetam.
Topics: Anticonvulsants; Fluoroscopy; Humans; Laryngeal Diseases; Laryngeal Muscles; Levetiracetam; Male; Mi | 2011 |
Amelioration of disabling myoclonus in a case of DRPLA by levetiracetam.
Topics: Adolescent; Anticonvulsants; Epilepsies, Myoclonic; Humans; Levetiracetam; Male; Myoclonic Epilepsie | 2012 |
[Involuntary movements in infantile cobalamin deficiency appearing during treatment].
Topics: Anemia, Megaloblastic; Atrophy; Brain; Consanguinity; Electroencephalography; Female; Humans; Hydrox | 2013 |
A case of amiodarone-associated myoclonus responsive to levetiracetam.
Topics: Aged, 80 and over; Amiodarone; Anticonvulsants; Humans; Levetiracetam; Male; Myoclonus; Piracetam | 2012 |
Functional neuroimages of cortical myoclonus altered by levetiracetam in a patient with sialidosis.
Topics: Adult; Cerebral Cortex; Humans; Levetiracetam; Male; Mucolipidoses; Myoclonus; Neuroimaging; Piracet | 2013 |
Amelioration of spinal myoclonus with levetiracetam.
Topics: Anticonvulsants; Child; Female; Herpes Zoster; Humans; Levetiracetam; Male; Middle Aged; Myelitis; M | 2002 |
[Favorable course of Lance-Adams postanoxic action myoclonus].
Topics: Anticonvulsants; Disease Progression; Electroencephalography; Electrophysiology; Humans; Hypoxia, Br | 2003 |
Levetiracetam control of myoclonus in a patient with Creutzfeldt-Jakob disease.
Topics: Adult; Anticonvulsants; Creutzfeldt-Jakob Syndrome; Humans; Levetiracetam; Male; Myoclonus; Piraceta | 2003 |
Suppression of myoclonus in SCA2 by piracetam.
Topics: Adult; Ataxia; Ataxins; Dose-Response Relationship, Drug; Gait Ataxia; Humans; Infusions, Intravenou | 2006 |
Antimyoclonic effect of levetiracetam in MERRF syndrome.
Topics: Activities of Daily Living; Anticonvulsants; Atrophy; Brain; Drug Therapy, Combination; Female; Gene | 2006 |
Post-anoxic myoclonus: a case presentation and review of management in the rehabilitation setting.
Topics: Anticonvulsants; Clonazepam; Diazepam; Female; Heart Arrest; Humans; Hypoxia, Brain; Isoxazoles; Lev | 2006 |
[Use of levetiracetam in the management of post-anoxic myoclonias. A report of two cases].
Topics: Adult; Anticonvulsants; Humans; Hypoxia, Brain; Levetiracetam; Male; Myoclonus; Piracetam | 2007 |
[Myoclonus of focal action and localized hemispheric lesion. A polygraphic and pharmacological study].
Topics: Anticonvulsants; Brain Diseases; Brain Ischemia; Cerebral Cortex; Clonazepam; Electroencephalography | 1995 |
Activated sialidase activity in transformed lymphocytes by Epstein-Barr (EB) virus of sialidosis type I (cherry-red spot-myoclonus syndrome).
Topics: Adolescent; Adult; Enzyme Activation; Female; Herpesvirus 4, Human; Humans; Lymphocyte Activation; L | 1995 |
The pathophysiology and pharmacology of photic cortical reflex myoclonus.
Topics: 5-Hydroxytryptophan; Aged; Aged, 80 and over; Ataxia; Cerebral Cortex; Dopamine Agents; Electroencep | 1993 |
Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats.
Topics: Amygdala; Animals; Anticonvulsants; Behavior, Animal; Dose-Response Relationship, Drug; Electrodes; | 1993 |
Cortical myoclonus in Angelman syndrome.
Topics: Adolescent; Adult; Angelman Syndrome; Anticonvulsants; Cerebral Cortex; Child; Child, Preschool; Chr | 1996 |
Clinical trial of piracetam in patients with myoclonus: nationwide multiinstitution study in Japan. The Myoclonus/Piracetam Study Group.
Topics: Administration, Oral; Adolescent; Adult; Aged; Disability Evaluation; Dose-Response Relationship, Dr | 1996 |
Cortical reflex myoclonus in Rett syndrome.
Topics: Adolescent; Adult; Anticonvulsants; Cerebral Cortex; Child; Child, Preschool; Electric Stimulation; | 1998 |
[Propriospinal myoclonus induced by relaxation and drowsiness].
Topics: Anticonvulsants; Baclofen; Clonazepam; Electrophysiology; Female; Humans; Middle Aged; Muscle Relaxa | 1998 |
[Effect of piracetam on urea-induced myoclonus in rats].
Topics: Animals; Clonazepam; Disease Models, Animal; Male; Myoclonus; Neuroprotective Agents; Nootropic Agen | 2000 |
Suppression of post-hypoxic and post-encephalitic myoclonus with levetiracetam.
Topics: Adult; Aged; Female; Humans; Hypoxia, Brain; Levetiracetam; Male; Middle Aged; Myoclonus; Piracetam; | 2001 |
[Treatment and long-term follow-up of post-anoxic myoclonus].
Topics: Adult; Cognition Disorders; Depressive Disorder, Major; Female; Humans; Hypoxia, Brain; Myoclonus; N | 2001 |
Piracetam in post-hypoxic action myoclonus.
Topics: Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Hypoxia, Brain; Injections, Int | 2001 |
The clinical challenge of posthypoxic myoclonus.
Topics: 5-Hydroxytryptophan; Anticonvulsants; Clonazepam; Humans; Hypoxia; Levetiracetam; Myoclonus; Neuropr | 2002 |
[Intention and post-anoxic action myoclonias. Amelioration by piracetam].
Topics: Female; Humans; Hypoxia; Middle Aged; Myoclonus; Piracetam; Pyrrolidinones | 1979 |
Effect of alcohol on action myoclonus in Lance-Adams syndrome and progressive myoclonus epilepsy.
Topics: Alcohol Drinking; Drug Tolerance; Epilepsies, Myoclonic; Follow-Up Studies; Humans; Myoclonus; Pirac | 1992 |
Newer drugs for posthypoxic action myoclonus: observations from a well-studied case.
Topics: Clonazepam; Drug Therapy, Combination; Estrogens, Conjugated (USP); Fasting; Female; Humans; Hydroxy | 1986 |
The treatment of severe action myoclonus.
Topics: Adolescent; Adult; Aged; Clonazepam; Drug Evaluation; Drug Therapy, Combination; Electromyography; E | 1989 |
Piracetam in the treatment of different types of myoclonus.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Drug Therapy, Combination; Electrophysiology; Evoked Poten | 1988 |
Myoclonus, delayed sequelae of carbon monoxide poisoning, piracetam trial.
Topics: Adult; Carbon Monoxide Poisoning; Humans; Male; Myoclonus; Piracetam; Pyrrolidinones | 1987 |